Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00063986 · ClinicalTrials.gov registry record · Phase 2
Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer
A Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT00063986 is a Phase 2 study that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 110 participants.
The verdict
NCT00063986, a Phase 2 study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
RATIONALE: Laparoscopic-assisted surgery and video-assisted thoracoscopy are less invasive types of surgery for esophageal cancer that may have fewer side effects and improve recovery. PURPOSE: This phase II trial is studying how well laparoscopic-assisted surgery and video-assisted thoracoscopy work in treating patients who are undergoing esophagectomy for high-grade dysplasia of the esophagus or stage I, stage II, or stage III esophageal cancer.
Interventions
- PROCEDURE Minimally invasive esophagectomy (MIE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2004-06-24 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00063986
The ClinicalTrials.gov registry entry for NCT00063986 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minimally invasive esophagectomy (MIE) is the first listed.
NCT00063986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00063986 about?
NCT00063986 is a clinical study titled "Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer". RATIONALE: Laparoscopic-assisted surgery and video-assisted thoracoscopy are less invasive types of surgery for esophageal cancer that may have fewer side effects and improve recovery. PURPOSE: This phase II trial is studying how well laparoscopic-assisted surgery and video-assisted thoracoscopy wo...
What is the current status of trial NCT00063986?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2004-06-24. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00063986?
The interventions under investigation include: Minimally invasive esophagectomy (MIE) (PROCEDURE).
Who is sponsoring clinical trial NCT00063986?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.